1. An overview of chitosan and its application in infectious diseases
- Author
-
Qingye Meng, Hao Hu, Hailin Cong, Ying Sun, and Fu-Jian Xu
- Subjects
Drug ,medicine.medical_specialty ,media_common.quotation_subject ,Pharmaceutical Science ,Biocompatible Materials ,02 engineering and technology ,medicine.disease_cause ,Communicable Diseases ,030226 pharmacology & pharmacy ,03 medical and health sciences ,Biosafety ,Nanoparticle ,0302 clinical medicine ,Sars virus ,Anti-Infective Agents ,Acquired immunodeficiency syndrome (AIDS) ,medicine ,Animals ,Humans ,Intensive care medicine ,media_common ,Coronavirus ,Chitosan ,Wound Healing ,Infectious disease ,Ebola virus ,Natural materials ,business.industry ,COVID-19 ,Vaccine vector ,021001 nanoscience & nanotechnology ,medicine.disease ,Bandages ,Anti-Bacterial Agents ,COVID-19 Drug Treatment ,Infectious disease (medical specialty) ,Wound dressing ,Original Article ,0210 nano-technology ,business - Abstract
Graphical Abstract Infectious diseases, such as the coronavirus disease-19, SARS virus, Ebola virus, and AIDS, threaten the health of human beings globally. New viruses, drug-resistant bacteria, and fungi continue to challenge the human efficacious drug bank. Researchers have developed a variety of new antiviral and antibacterial drugs in response to the infectious disease crisis. Meanwhile, the development of functional materials has also improved therapeutic outcomes. As a natural material, chitosan possesses good biocompatibility, bioactivity, and biosafety. It has been proven that the cooperation between chitosan and traditional medicine greatly improves the ability of anti-infection. This review summarized the application and design considerations of chitosan-composed systems for the treatment of infectious diseases, looking forward to providing the idea of infectious disease therapy.
- Published
- 2021
- Full Text
- View/download PDF